Registration for AMCP is not required. All attendees must be fully vaccinated.
Friday, April 1, 2022
6:30 AM – 7:00 AM Local Time: Registration & Breakfast
7:00 AM – 8:00 AM Local Time: Symposium
McCormick Place Convention Center
2301 S King Drive
Chicago, IL 60616
Meeting Room: E350
PROGRAM FEATURES
- Online personalized quality-improvement poster-generation portal
- Downloadable whiteboard animations
FACULTY
Geoffrey C. Wall, PharmD, FCCP, BCPS
John R. Ellis Distinguished Chair of Pharmacy Practice
Professor of Clinical Sciences
Director, Drake Drug Information Center
Drake University College of Pharmacy and Health Sciences
Internal Medicine Clinical Pharmacist
Iowa Methodist Medical Center
Des Moines, IA
Hassan Nasir, DO
Allergy & Immunology
Memorial Healthcare
Owosso, MI
LEARNING OBJECTIVES
After completing the CME activity, learners should be better able to:
- Consider the costs and burdens of chronic rhinosinusitis with nasal polyps (CRSwNP), including pathophysiology and associated comorbidities from a managed care perspective
- Summarize clinical data and biomarkers concerning the use of novel anti-inflammatory biologics for the management of CRSwNP, including relevant costs of care and managed care considerations
- Implement best practices for protocolized treatment of CRSwNP through development of individualized treatment plans with a managed care perspective
TARGET AUDIENCE
This CME initiative is designed to meet the educational needs of managed care practitioners and other members of the multidisciplinary team including allergists, otolaryngologists, primary care physicians, nurses, nurse practitioners, and pharmacists, to attain an up-to-date understanding of the latest data in management of chronic rhinosinusitis with nasal polyps.
ACCREDITATION STATEMENT
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
CREDIT DESIGNATION STATEMENT
Med Learning Group designates this live activity for a maximum of 1.0 AMA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the live activity.
NURSING CREDIT INFORMATION
Purpose: This program would be beneficial for nurses involved in the care of patients with chronic rhinosinusitis with nasal polyps.
CNE Credits: 1.0 ANCC Contact Hour.
CNE Accreditation Statement: Ultimate Medical Academy/CCM is accredited as a provider of nursing continuing professional education by the American Nurses Credentialing Center’s Commission on Accreditation. Awarded 1.0 contact hours of continuing nursing education of RNs and APNs.
ACCREDITATION STATEMENT
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Med Learning Group. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHARMACISTS AND PHARMACY TECHNICIANS (ACPE) CREDIT DESIGNATION
Amedco LLC designates this activity for a maximum of 1.0 knowledge-based CPE contact hours.
NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 30 days of your participation in the activity to meet the deadline for submission to CPE Monitor.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
DISCLAIMER
Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact Med Learning Group at [email protected]
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc.). Please contact Med Learning Group prior to the live event at [email protected]
